65 related articles for article (PubMed ID: 38674199)
21. Development of pH/Glutathione-Responsive Theranostic Agents Activated by Glutathione S-Transferase π for Human Colon Cancer.
Liu J; Liu X; Qian J; Meng C; Zhu P; Hang J; Wang Y; Xiong B; Qiu X; Zhu W; Yang Y; Zhang Y; Ling Y
J Med Chem; 2020 Sep; 63(17):9271-9283. PubMed ID: 32787089
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance and biological mechanisms of glutathione S-transferase mu gene family in colon adenocarcinoma.
Guo E; Wei H; Liao X; Wu L; Zeng X
BMC Med Genet; 2020 Jun; 21(1):130. PubMed ID: 32539715
[TBL] [Abstract][Full Text] [Related]
23. The Influence of Red Meat on Colorectal Cancer Occurrence Is Dependent on the Genetic Polymorphisms of S-Glutathione Transferase Genes.
Klusek J; Nasierowska-Guttmejer A; Kowalik A; Wawrzycka I; Chrapek M; Lewitowicz P; Radowicz-Chil A; Klusek J; Głuszek S
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31336627
[TBL] [Abstract][Full Text] [Related]
24. Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development.
Stojkovic Lalosevic ML; Coric VM; Pekmezovic TD; Simic TP; Pljesa Ercegovac MS; Pavlovic Markovic AR; Krivokapic ZV
Pathol Oncol Res; 2019 Oct; 25(4):1579-1587. PubMed ID: 30694518
[TBL] [Abstract][Full Text] [Related]
25. Glutathione Transferases: Potential Targets to Overcome Chemoresistance in Solid Tumors.
Pljesa-Ercegovac M; Savic-Radojevic A; Matic M; Coric V; Djukic T; Radic T; Simic T
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30487385
[TBL] [Abstract][Full Text] [Related]
26. Molecular evaluation of glutathione S transferase family genes in patients with sporadic colorectal cancer.
Rodrigues-Fleming GH; Fernandes GMM; Russo A; Biselli-Chicote PM; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
World J Gastroenterol; 2018 Oct; 24(39):4462-4471. PubMed ID: 30356976
[TBL] [Abstract][Full Text] [Related]
27. Association of glutathione S-transferase M1 polymorphisms in the colorectal cancer risk: A meta-analysis.
Huang M; Zeng Y; Zhao F; Huang Y
J Cancer Res Ther; 2018 Jan; 14(1):176-183. PubMed ID: 29516983
[TBL] [Abstract][Full Text] [Related]
28. Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases.
Allocati N; Masulli M; Di Ilio C; Federici L
Oncogenesis; 2018 Jan; 7(1):8. PubMed ID: 29362397
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer-global burden, trends, and geographical variations.
Douaiher J; Ravipati A; Grams B; Chowdhury S; Alatise O; Are C
J Surg Oncol; 2017 Apr; 115(5):619-630. PubMed ID: 28194798
[TBL] [Abstract][Full Text] [Related]
30. Determinants of metastatic competency in colorectal cancer.
Tauriello DV; Calon A; Lonardo E; Batlle E
Mol Oncol; 2017 Jan; 11(1):97-119. PubMed ID: 28085225
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis.
Shahnam A; Ridha Z; Wiese MD; Kichenadasse G; Sorich MJ
Pharmacogenomics; 2016 Oct; 17(15):1725-1732. PubMed ID: 27636246
[TBL] [Abstract][Full Text] [Related]
32. Familial Colorectal Cancer: Understanding the Alphabet Soup.
Giglia MD; Chu DI
Clin Colon Rectal Surg; 2016 Sep; 29(3):185-95. PubMed ID: 27582643
[TBL] [Abstract][Full Text] [Related]
33. Can GSTM1 and GSTT1 polymorphisms predict clinical outcomes of chemotherapy in gastric and colorectal cancers? A result based on the previous reports.
Liu H; Shi W; Zhao L; Dai D; Gao J; Kong X
Onco Targets Ther; 2016; 9():3683-94. PubMed ID: 27382306
[TBL] [Abstract][Full Text] [Related]
34. Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer.
Mehrzad V; Roayaei M; Peikar MS; Nouranian E; Mokarian F; Khani M; Farzannia S
Adv Biomed Res; 2016; 5():10. PubMed ID: 26962512
[TBL] [Abstract][Full Text] [Related]
35. Association between glutathione S-transferase M1 and T1 polymorphisms and colorectal cancer risk in patients from Kazakhstan.
Zhunussova G; Zhunusbekova B; Djansugurova L
Clin Lab; 2015; 61(1-2):161-8. PubMed ID: 25807650
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin.
Kap EJ; Richter S; Rudolph A; Jansen L; Ulrich A; Hoffmeister M; Ulrich CM; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2014 Jul; 24(7):340-7. PubMed ID: 24842074
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms of
Kumamoto K; Ishibashi K; Okada N; Tajima Y; Kuwabara K; Kumagai Y; Baba H; Haga N; Ishida H
Oncol Lett; 2013 Sep; 6(3):648-654. PubMed ID: 24137384
[TBL] [Abstract][Full Text] [Related]
38. Glutathione transferases, regulators of cellular metabolism and physiology.
Board PG; Menon D
Biochim Biophys Acta; 2013 May; 1830(5):3267-88. PubMed ID: 23201197
[TBL] [Abstract][Full Text] [Related]
39. Genetic variability of glutathione S-transferase enzymes in human populations: functional inter-ethnic differences in detoxification systems.
Polimanti R; Carboni C; Baesso I; Piacentini S; Iorio A; De Stefano GF; Fuciarelli M
Gene; 2013 Jan; 512(1):102-7. PubMed ID: 23043933
[TBL] [Abstract][Full Text] [Related]
40. Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population.
Hezova R; Bienertova-Vasku J; Sachlova M; Brezkova V; Vasku A; Svoboda M; Radová L; Kiss I; Vyzula R; Slaby O
Eur J Med Res; 2012 Jun; 17(1):17. PubMed ID: 22697302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
